Compare Stitch Fix Inc (SFIX) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Stitch Fix Inc vs TransMedics Group Inc — how do they compare? Stitch Fix Inc trades at $3.79 (market cap $497.68M), while TransMedics Group Inc trades at $89.19 (market cap $3.10B). The key difference: TransMedics Group Inc is far larger — about 6.2× Stitch Fix Inc's market cap. Which is the better fit depends on your goals.
| SFIX | TMDX | |
|---|---|---|
Market Cap | $497.68M | $3.10B |
Sector | Consumer Cyclical | Technology |
52-Week High | $5.83 | $150.42 |
52-Week Low | $3.06 | $61.99 |
Enterprise Value | $385.40M | $3.49B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Stitch Fix Inc
Stitch Fix Inc offers personal style service for men and women. The company engages in delivering one-to-one personalization to clients through the combination of data science and human judgment. It provides a shipment service called A FIX where the stylist's hand selects items from several merchandises with analysis of client and merchandise data to provide a personalized shipment of apparel, shoes, and accessories suited to the client's needs. The company offers products across categories, brands, product types and price points including Women's, Petite, Maternity, Men's and Plus. It also offers various product types, including denim, dresses, blouses, skirts, shoes, jewelry and handbags, and sells merchandise across various range of price points.
Read more on SFIX →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
